Prime Medicine, Inc. (PRME)
3.67
-0.06
(-1.61%)
USD |
NASDAQ |
Oct 23, 16:00
3.60
-0.07
(-1.91%)
After-Hours: 20:00
Prime Medicine Market Cap : 663.31M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 663.31M |
| October 22, 2026 | 674.15M |
| October 21, 2026 | 688.61M |
| October 20, 2026 | 708.49M |
| October 19, 2026 | 692.22M |
| October 16, 2026 | 627.16M |
| October 15, 2026 | 652.46M |
| October 14, 2026 | 565.71M |
| October 13, 2026 | 600.05M |
| October 12, 2026 | 652.46M |
| October 09, 2026 | 721.14M |
| October 08, 2026 | 647.04M |
| October 07, 2026 | 704.88M |
| October 06, 2026 | 632.58M |
| October 05, 2026 | 580.17M |
| October 02, 2026 | 538.60M |
| October 01, 2026 | 540.41M |
| September 30, 2026 | 552.15M |
| September 29, 2026 | 558.48M |
| September 28, 2026 | 519.62M |
| September 25, 2026 | 524.14M |
| September 24, 2026 | 554.86M |
| September 23, 2026 | 565.71M |
| September 22, 2026 | 639.81M |
| September 21, 2026 | 576.55M |
| Date | Value |
|---|---|
| September 18, 2026 | 563.90M |
| September 17, 2026 | 567.52M |
| September 16, 2026 | 542.21M |
| September 15, 2026 | 567.52M |
| September 14, 2026 | 574.75M |
| September 11, 2026 | 565.71M |
| September 10, 2026 | 605.47M |
| September 09, 2026 | 627.16M |
| September 08, 2026 | 643.43M |
| September 04, 2026 | 668.73M |
| September 03, 2026 | 670.54M |
| September 02, 2026 | 663.31M |
| September 01, 2026 | 645.23M |
| August 31, 2026 | 648.85M |
| August 28, 2026 | 652.46M |
| August 27, 2026 | 657.88M |
| August 26, 2026 | 647.04M |
| August 25, 2026 | 670.54M |
| August 24, 2026 | 587.40M |
| August 21, 2026 | 612.70M |
| August 20, 2026 | 585.59M |
| August 19, 2026 | 639.81M |
| August 18, 2026 | 551.25M |
| August 17, 2026 | 572.94M |
| August 14, 2026 | 558.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.570B |
| Beam Therapeutics, Inc. | 2.484B |
| Twist Bioscience Corp. | 8.769B |
| Moderna, Inc. | 79.84B |
| Q32 Bio, Inc. | 205.32M |
Market Cap Related Metrics
| PS Ratio | 156.63 |
| Price to Book Value | 16.66 |
| Price | 3.67 |
| Earnings Yield | -29.58% |